PmrD is required for modifications to escherichia coli endotoxin that promote antimicrobial resistance

Erica J Rubin1, Carmen M Herrera2, Alexander A Crofts2

  • 1Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, Texas, USA.

Insights

The Escherichia coli PmrD protein is essential for modifying lipid A, enhancing resistance to antimicrobial peptides. This study reveals PmrD

Area of Science:

  • Microbiology
  • Molecular Biology
  • Bacterial Pathogenesis

Background:

  • PmrD in Salmonella enterica links PhoP-PhoQ and PmrA-PmrB two-component systems.
  • An Escherichia coli PmrD homolog was previously thought incapable of linking these systems.
  • Low Mg(2+) induces PmrA-PmrB-dependent lipid A modifications in E. coli, conferring resistance to cationic antimicrobial peptides (CAMPs).

Purpose of the Study:

  • To investigate the role of pmrD in E. coli lipid A modification under low Mg(2+) conditions.
  • To elucidate the regulatory network involving PhoPQ, PmrAB, and PmrD in E. coli.

Main Methods:

  • Phenotypic analysis of E. coli pmrD mutants.
  • RNA sequencing to assess gene expression changes.
  • Bacterial survival assays against polymyxin B.

Main Results:

  • pmrD is required for E. coli lipid A modification with phosphoethanolamine (pEtN) and 4-amino-4-deoxy-l-arabinose (l-Ara4N) under low Mg(2+).
  • E. coli pmrD influences the expression of pmrA and genes encoding lipid A modification enzymes.
  • A pmrD mutant exhibits significantly reduced survival against polymyxin B compared to wild-type E. coli.
  • An unknown factor activates pmrD independently of the PhoPQ system.

Conclusions:

  • E. coli PmrD plays a crucial role in lipid A modification and CAMP resistance.
  • The PhoPQ-PmrAB regulatory network in E. coli is more complex than previously understood, involving PmrD.
  • The discovery of a PhoPQ-independent activation pathway for PmrD opens new avenues for research.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.1K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
158
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
61
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
70
Antibiotic Selection00:57

Antibiotic Selection

Overview
62.4K
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
494